-
Biologics and targeted therapy for severe refractory asthma
According to Asthma Canada, 3.8-million Canadians suffer from this chronic inflammatory condition and estimates 250,000 have severe asthma. Asthma has entered the era of personalized medicine with therapies that target specific inflammatory pathways in people with severe disease who don’t respond to normal inhaler therapy. -
Pharmacy Leader Lindsay Mildenberger: "My favourite part of pharmacy is watching passion ignite in fellow pharmacy colleagues."
Healthcare is in constant change and the pace of change in pharmacy seems to be accelerating. As we continue to advocate for additions to our scope of practice, it is important to ensure that we are embracing all the opportunities that come our way.

